EphA2 monoclonal antibodies and methods of use thereof

Details for Australian Patent Application No. 2003243228 (hide)

Owner MedImmune, LLC

Inventors Carles-Kinch, Kelly; Kiener, Peter; Langermann, Solomon; Kinch, Michael S.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003243228

PCT Number PCT/US03/15044

PCT Pub. Number WO2003/094859

Priority 60/460,507 03.04.03 US; 60/418,213 14.10.02 US; 60/379,322 10.05.02 US

Filing date 12 May 2003

Wipo publication date 24 November 2003

Acceptance publication date 26 March 2009

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/460,507 03.04.03 US; 60/418,213 14.10.02 US; 60/379,322 10.05.02 US

15 January 2004 Application Open to Public Inspection

  Published as AU-B-2003243228

2 October 2008 Alteration of Name

  The name of the applicant has been altered to MedImmune, LLC

26 March 2009 Application Accepted

  Published as AU-B-2003243228

23 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003243229-DSL MOBILE ACCESS ROUTER SYSTEM AND METHOD

2003243227-DNA SEQUENCE CONFERING EARLY AND INCREASED SECONDARY METABOLITE PRODUCTION IN STREPTOMYCES AND METHOD OF USE